Marshall Wace, LLP Genetron Holdings LTD Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.28 - $2.4 $201,768 - $378,316	-157,632 Reduced 43.24%	206,928 $351,000
Q1 2022 May 16, 2022	BUY	$2.19 - $6.09 $750,510 - $2.09 Million	342,699 Added 1567.63%	364,560 $798,000
Q4 2021 Feb 14, 2022	BUY	$5.81 - $14.39 $38,822 - $96,153	6,682 Added 44.02%	21,861 $133,000
Q2 2021 Aug 13, 2021	SELL	$17.9 - $23.29 $3.38 Million - $4.4 Million	-188,779 Reduced 92.56%	15,179 $306,000
Q1 2021 May 17, 2021	BUY	$13.71 - $30.64 $1.22 Million - $2.73 Million	89,026 Added 77.46%	203,958 $4.38 Million
Q4 2020 Feb 16, 2021	BUY	$9.31 - $14.0 $1.07 Million - $1.61 Million	114,932 New	114,932 $1.61 Million

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.